MacroGenics
MGNX
#8233
Rank
NZ$0.54 B
Marketcap
NZ$8.52
Share price
3.22%
Change (1 day)
326.83%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): NZ-$0.20

According to MacroGenics's latest financial reports the company's current EPS (TTM) is NZ-$0.08862. In 2024 the company made an earnings per share (EPS) of NZ-$1.90 a decrease over its 2023 EPS that were of NZ-$0.27.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.20-89.58%
2024NZ-$1.90613.33%
2023NZ-$0.27-92.31%
2022NZ-$3.46-42.14%
2021NZ-$5.9736.44%
2020NZ-$4.38-21.84%
2019NZ-$5.60-24.58%
2018NZ-$7.43675.93%
2017NZ-$0.96-68.05%
2016NZ-$3.00168.25%
2015NZ-$1.12-55%
2014NZ-$2.483400%
2013NZ-$0.07089-108.68%
2012NZ$0.8224.49%
2011NZ$0.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.32-2,720.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$50.02-56,550.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$25.66-29,060.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$12.14-13,800.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.30-7,214.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.31-7,220.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ-$3.14 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA